» Articles » PMID: 20871122

Prevalence of Major Comorbidities in Subjects with COPD and Incidence of Myocardial Infarction and Stroke: a Comprehensive Analysis Using Data from Primary Care

Overview
Journal Thorax
Date 2010 Sep 28
PMID 20871122
Citations 160
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Comorbidities associated with systemic inflammation including cardiovascular disease (CVD), stroke and diabetes mellitus (DM) are common among individuals with chronic obstructive pulmonary disease (COPD). A study was undertaken to quantify the burden of comorbidity and to determine the risk of first acute arteriovascular events among individuals with COPD.

Methods: The computerised primary care records of 1,204,100 members of the general population aged ≥ 35 years on 25 February 2005 were searched for recordings of each disease. Data were analysed using multivariate logistic regression. Cox regression was used to determine whether individuals with COPD were at increased risk of acute myocardial infarction (MI) and stroke.

Results: Cross-sectional analyses showed that physician-diagnosed COPD was associated with increased risks of CVD (OR 4.98, 95% CI 4.85 to 5.81; p<0.001), stroke (OR 3.34, 95% CI 3.21 to 3.48; p<0.001) and DM (OR 2.04, 95% CI 1.97 to 2.12; p<0.001). In the follow-up analyses, after adjusting for confounding by sex and smoking status and stratifying for age, the greatest increase in the rate of acute arteriovascular events was found in the youngest age groups; the HR for acute MI was 10.34 (95% CI 3.28 to 32.60; p<0.001) and for stroke the HR was 3.44 (95% CI 0.85 to 13.84; p<0.001) compared with the oldest age group.

Conclusion: Individuals with COPD are substantially more likely to have pre-existing CVD, DM or a previous stroke and are at high risk of acute arteriovascular events. National COPD guidelines and models of care need to adapt to provide an integrated approach to addressing these comorbidities.

Citing Articles

Catlet scoring system as a new predictor for in-stent restenosis in patients with chronic coronary artery disease undergoing percutaneous coronary intervention with drug-eluting stent.

Wang J, Zhang M, Gan W, Xu M, Zhou J, Yang L J Cardiothorac Surg. 2025; 20(1):106.

PMID: 39881392 PMC: 11776114. DOI: 10.1186/s13019-025-03349-2.


Improving COPD Management at Transitions of Care.

Kaplan A Fed Pract. 2025; 41(Suppl 6):S29-S34.

PMID: 39839062 PMC: 11745471. DOI: 10.12788/fp.0533.


Prevalence and Impact of Chronic Obstructive Pulmonary Disease in Ischemic Heart Disease: A Systematic Review and Meta-Analysis of 18 Million Patients.

Meng K, Zhang X, Liu W, Xu Z, Xie B, Dai H Int J Chron Obstruct Pulmon Dis. 2024; 19:2333-2345.

PMID: 39465033 PMC: 11512537. DOI: 10.2147/COPD.S474223.


An Italian Delphi Consensus on the Triple inhalation Therapy in Chronic Obstructive Pulmonary Disease.

Solidoro P, Dente F, Micheletto C, Pappagallo G, Pelaia G, Papi A Multidiscip Respir Med. 2024; 19.

PMID: 39291458 PMC: 11414512. DOI: 10.5826/mrm.2024.949.


Cardiovascular Risk in Patients with Chronic Obstructive Pulmonary Disease: A Systematic Review.

Sa-Sousa A, Rodrigues C, Jacome C, Cardoso J, Fortuna I, Guimaraes M J Clin Med. 2024; 13(17).

PMID: 39274386 PMC: 11396696. DOI: 10.3390/jcm13175173.